1260772-97-1 Usage
General Description
1-Piperidinecarboxylic acid, 4-fluoro-3-hydroxy-, 1,1-diMethylethyl ester, also known as baclofen, is a medication used to treat spasticity. It works by acting on the nerves in the spinal cord and decreasing the number and severity of muscle spasms caused by multiple sclerosis or spinal cord injuries. Baclofen is a derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), and its mechanism of action involves binding to GABA receptors and reducing the release of excitatory neurotransmitters. It is available as an oral medication and is also sometimes administered intrathecally via a pump implant. Side effects of baclofen may include drowsiness, dizziness, weakness, and fatigue, and it should be used cautiously in individuals with a history of seizures or kidney disease.
Check Digit Verification of cas no
The CAS Registry Mumber 1260772-97-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,7,7 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1260772-97:
(9*1)+(8*2)+(7*6)+(6*0)+(5*7)+(4*7)+(3*2)+(2*9)+(1*7)=161
161 % 10 = 1
So 1260772-97-1 is a valid CAS Registry Number.
1260772-97-1Relevant articles and documents
NOVEL HETEROCYCLYL COMPOUNDS
-
Page/Page column 26-27, (2011/05/03)
The invention is concerned with novel bicyclic compounds of formula (I), wherein n, m, p, A, L, R1, R2, R3, R4, R5, R6, R7, R7, R8, R9, and R10 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor may be used, for example, in the prevention and/or treatment of inflammatory diseases, particularly peripheral arterial occlusive diseases or atherothrombosis.
